Leonard Sank's most recent trade in Oramed Pharmaceuticals, Inc was a trade of 30,000 Common Stock done . Disclosure was reported to the exchange on June 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Oramed Pharmaceuticals Inc | Leonard Sank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 30,000 | 128,021 (0%) | 0% | - | Common Stock | |
| Oramed Pharmaceuticals Inc | Leonard Sank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 6,510 | 134,531 (0%) | 0% | - | Common Stock | |
| Oramed Pharmaceuticals Inc | Leonard Sank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 30,000 | 88,696 (0%) | 0% | - | Common Stock | |
| Oramed Pharmaceuticals Inc | Leonard Sank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 9,325 | 98,021 (0%) | 0% | - | Common Stock | |
| Oramed Pharmaceuticals Inc | Leonard Sank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 30,000 | 58,696 (0%) | 0% | - | Common Stock | |
| Oramed Pharmaceuticals Inc | Leonard Sank | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2022 | 20,000 | 0 | - | - | Stock Option | |
| Oramed Pharmaceuticals Inc | Leonard Sank | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.08 per share. | 08 Aug 2022 | 20,000 | 38,000 (0%) | 0% | 4.1 | 81,600 | Common Stock |
| Oramed Pharmaceuticals Inc | Leonard Sank | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.77 per share. | 08 Aug 2022 | 9,304 | 28,696 (0%) | 0% | 8.8 | 81,596 | Common Stock |
| Oramed Pharmaceuticals Inc | Leonard Sank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2022 | 12,000 | 18,000 (0%) | 0% | - | Common Stock | |
| Oramed Pharmaceuticals Inc | Leonard Sank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Oramed Pharmaceuticals Inc | Leonard Sank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 6,000 | 6,000 (0%) | 0% | - | Common Stock | |
| Oramed Pharmaceuticals Inc | Leonard Sank | Director | Other type of transaction at price $ 3.68 per share. | 26 Feb 2021 | 375,000 | 0 (0%) | 2% | 3.7 | 1,380,000 | Common Stock |
| Oramed Pharmaceuticals Inc | Leonard Sank | Director | Other type of transaction at price $ 3.68 per share. | 26 Feb 2021 | 78,125 | 0 (0%) | 0% | 3.7 | 287,500 | Common Stock |